- Home
- Equipment
- latin america
- hiv recent
Refine by
Locations
- Latin America
- Antigua & Barbuda
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Cuba
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Jamaica
- Mexico
- Netherlands Antilles
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- St. Kitts & Nevis
- St. Lucia
- St. Vincent & The Grenadines
- Suriname
- Trinidad
- Uruguay
- Venezuela
Hiv Recent Equipment & Supplies Near Latin America
5 equipment items found
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim Swift HIV Recent Infection Assay (RIA) is a single use qualitative immunoassay to detect the circulating antibodies to Human Immunodeficiency Virus Type 1 (HIV-1), Type 2 (HIV-2) and distinguish between recent and long-term infection in HIV-1/2. The assay is a point of care (POC) test ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim Swift HIV Recent Infection Assay (RIA) Kit Controls are quality control reagents for use only with the Maxim Swift™ HIV Recent Infection Assay (RIA) (P/N 92002). They are used to verify that the test kit reagents are working and that the test is performed correctly. The Maxim Swift™ HIV RIA ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 ...
Manufactured by:Sedia Biosciences Corporation based inBeaverton, OREGON (USA)
An in vitro single well quantitative limiting antigen avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Intended for use with liquid serum or plasma specimens. ...